Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation

被引:66
作者
Chou, WC
Chen, HY
Yu, SL
Cheng, LZ
Yang, PC
Dang, CV
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[2] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan
[4] Natl Taiwan Univ, Coll Med, Taipei 10018, Taiwan
[5] Natl Taiwan Univ, Grad Inst Epidemiol, Taipei 10018, Taiwan
[6] Johns Hopkins Univ, Sch Med, Dept Med, Program Human Genet & Mol Biol,Inst Cell Engn, Baltimore, MD 21205 USA
[7] Johns Hopkins Univ, Sch Med, Kimmel Canc Ctr, Baltimore, MD 21205 USA
关键词
D O I
10.1182/blood-2005-01-0241
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The mechanism by which arsenic dramatically affects gene expression remains poorly understood. Here we report that prolonged exposure of acute promyelocytic leukemia NB4 cells to low levels of arsenic trioxide increased the expression of a set of genes responsible for reactive oxygen species (ROS) production. We hypothesize that arsenic-induced ROS in turn contribute partially to altered gene expression. To identify genes responsive to arsenic-induced ROS, we used microarray gene expression analysis and identified genes that responded to arsenic and hydrogen peroxide but whose response to arsenic was reversed by an ROS scavenger, N-acetyl-L-cysteine. We found that 26 % of the genes significantly responsive to arsenic might have been directly altered by ROS. We further explored the mechanisms by which ROS affects gene regulation and found that the Sp1 transcription factor was oxidized by arsenic treatment, with a corresponding decrease in its in situ binding on the promoters of 3 genes, hTERT, C17, and c-Myc, whose expressions were significantly suppressed. We conclude that ROS contributed partly to arsenic-mediated gene regulation and that Sp1 oxidation contributed to gene suppression by arsenic-induced ROS.
引用
收藏
页码:304 / 310
页数:7
相关论文
共 46 条
[41]   History of the development of arsenic derivatives in cancer therapy [J].
Waxman, S ;
Anderson, KC .
ONCOLOGIST, 2001, 6 :3-10
[42]   Oxidation of zinc finger transcription factors: Physiological consequences [J].
Webster, KA ;
Prentice, H ;
Bishopric, NH .
ANTIOXIDANTS & REDOX SIGNALING, 2001, 3 (04) :535-548
[43]   Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation [J].
Welling, MM ;
Hiemstra, PS ;
van den Barselaar, MT ;
Paulusma-Annema, A ;
Nibbering, PH ;
Pauwels, EKJ ;
Calame, W .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (08) :1583-1590
[44]   Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects [J].
Wu, MM ;
Chiou, HY ;
Ho, IC ;
Chen, CJ ;
Lee, TC .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2003, 111 (11) :1429-1438
[45]   Lipopolysaccharide down-regulates Sp1 binding activity by promoting Sp1 protein dephosphorylation and degradation [J].
Ye, XB ;
Liu, SF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (35) :31863-31870
[46]   How acute promyelocytic leukaemia revived arsenic [J].
Zhu, J ;
Chen, Z ;
Lallemand-Breitenbach, V ;
de Thé, H .
NATURE REVIEWS CANCER, 2002, 2 (09) :705-713